title: Predonation screening of candidate donors and prevention of window period donations.
abstract: BACKGROUND
  Infectious window period donations slip through routine donor screening procedures. To explore the potential value of predonation screening of candidate donors, we compared the proportion of incident transfusion-transmissible infections in candidate donors, in first-time donors, and in repeat donors.
  
  
  METHODS
  A retrospective analysis was performed of all incident hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) infections in candidate, first-time, and repeat donors in the Netherlands during the period 2009 to 2013.
  
  
  RESULTS
  In total, 176,716 candidate donors, 144,226 first-time donations, and 4,143,455 repeat donations were screened for HBV, HCV, and HIV infection. Acute HBV infection was identified in the predonation sample of six candidate donors. One first-time donor, testing HIV-negative at predonation screening, tested positive for anti-HIV and HIV RNA in the first donation 29 days later. Among repeat donations we identified 15, one, and six incident HBV, HCV and HIV infections, respectively. The proportion of incident infections among candidate donors/first-time donations/repeat donations was for HBV, 3.40/0/0.36; for HCV, 0/0/0.02; and for HIV 0/0.69/0.14 per 100,000, respectively.
  
  
  CONCLUSIONS
  Predonation screening of candidate donors very likely causes a loss of donations, but it might prevent undetected window period donations. Further studies are necessary to determine the value of predonation screening as an additional safety measure.
authors.affiliation: Department of Blood-Borne Infections, Sanquin Blood Supply Foundation, Amsterdam, the Netherlands.
authors.forename: Ryanne W
authors.initials: RW
authors.lastname: Lieshout-Krikke
authors.forename: Hans L
authors.initials: HL
authors.lastname: Zaaijer
authors.forename: Thijs J W
authors.initials: TJ
authors.lastname: van de Laar
mesh_terms: D000328:Adult; D001782:Blood Donors; D046148:Donor Selection / Q000379:methods*; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D015497:HIV-1; D016174:Hepacivirus; D006509:Hepatitis B / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006515:Hepatitis B virus; D006526:Hepatitis C / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D015994:Incidence; D008297:Male; D012189:Retrospective Studies; D013997:Time Factors